Clinical trial
The UPGRADE Study: Real World Outcomes® of Differential Target Multiplexed (DTM-SCS®) Stimulation in Existing and New Medtronic Implants
NCT04725838 is registered in ClinicalTrials.gov with Celéri Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The UPGRADE Study: Real World Outcomes® of Differential Target Multiplexed (DTM-SCS®) Stimulation in Existing and New Medtronic Implants
- Lead sponsor
- Celéri Health, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 29, 2021
- Completion date
- July 1, 2023
- Enrollment
- 255 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.